3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Squamous Intraepithelial Lesions
1
Skin Neoplasms
1
Precancerous Conditions
1
Papillomavirus Infections
1
Papilloma
1
Lung Neoplasms
1
Laryngeal papillomatosis
1
Keratosis, Actinic
1
Hyperthermia
1
HIV Infections
1
Cicatrix
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Anus Neoplasms
1
Acquired Immunodeficiency Syndrome
1
Interventions
VGX-3100
4
Watchful Waiting
2
Light Coagulation
2
Imiquimod
2
Fluorouracil
2
Electroporation
2
Biopsy
2
Radiofrequency Ablation
1
Polymerase Chain Reaction
1
Observation
1
Megestrol Acetate
1
Laser Therapy
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Gene Expression Profiling
1
Electroporation Therapies
1
DNA Methylation
1
Cidofovir
1
4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Squamous Intraepithelial Lesions
×
Laser Therapy
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts